hSCRO Committee Meetings and Deadlines

The hSCRO Full Committee meets once a month on the first Thursday of the month and will review the following types of submissions:

  • All New hSCRO research protocols
  • Addition of new cell lines or materials as listed under “Activities that required hSCRO review” if materials are not from federally/state-funded established cell repositories and/or provenance documentation has not been previously reviewed by UCI hSCRO.
  • Amendments containing substantial changes to the specific aims or design of the study.
  • In vivo transplantation of pluripotent stem cells, cells of fetal origin or neural stem cells (with the exception of the addition of teratoma assays which qualify for expedited review).

hSCRO Full Committee Meeting Schedule

(deadline for submission and corresponding meeting dates)

Deadline DateMeeting Date
December 14, 2023January 4, 2024
January 11, 2024February 1, 2024
February 15, 2024March 7, 2024
March 14, 2024April 4, 2024
April 11, 2024May 2, 2024
May 16, 2024June 6, 2024
June 20, 2024July 11, 2024
July 11, 2024August 1, 2024
August 15, 2024September 5, 2024
September 12, 2024October 3, 2024
October 10, 2024November 7, 2024
November 14, 2024December 5, 2024
December 12, 2024January 2, 2025


Expedited review by the hSCRO Subcommittee is performed at weekly meetings. The following types of transactions qualify for expedited review:

  • Proposed changes in research related to activities that do not significantly affect the assessment of the ethical and social issues, and do not substantially change the specific aims or design of the study.
  • Addition of teratoma assay standard in vivo procedures
  • Additions of registered cell lines, cell lines/ materials that have been previously approved by UCI hSCRO or cell lines obtained from source material that has previously been verified by UCI hSCRO including standard fluorescent reporter lines (such as GFP). Note:  federally/state-funded cell established repositories (such as the NIH registry) are considered already verified sources.
  • Renewal submissions for already approved hSCRO research, unless the research has had any instance of noncompliance or unanticipated problems during the previous year of approval.


Administrative review by hSCRO Committee designated staff is performed on a rolling basis for the following types of submissions:

  • Addition or deletion of personnel as long as key research personnel are not deleted from the study team.
  • Updates in study locations and cell storage locations.
  • Deletions of cell lines.